Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder

Neuropharmacology

Volumn 49, Issue 6, 2005, Pages 724-736

  Mazei Robison, Michelle S ^a   Couch, R Steven ^b   Shelton, Richard C ^a,b   Stein, Mark A ^c   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dopamine; Genetics; Polymorphism; Transporter; Variable number tandem repeat

Indexed keywords

ALANINE; DOPAMINE TRANSPORTER; GENOMIC DNA; VALINE;

3' UNTRANSLATED REGION; AFRICAN AMERICAN; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ALANINE; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COHORT STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROPHORESIS, CAPILLARY; EXONS; FAMILY HEALTH; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VALINE; VARIATION (GENETICS);

EID: 26944484406     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.08.003     Document Type: Article

References (75)

1. P.J. Ambrosini Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS) Journal of the American Academy of Child and Adolescent Psychiatry 39 2000 49 58
2. APA Attention-Deficit and Disruptive Behavior Disorders, in: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 1994 American Psychiatric Association Washington, DC
3. Bannon, M.J., Sacchetti, P., Granneman, J.G., 1998. The Dopamine Transporter: Potential Involvement in Neuropsychiatric Disorders, in: Watson, S.J. (Ed.), Psychopharmacology: The Fourth Generation of Progress. On-line: http://www.acnp.org/G4. revised in 2000.
4. C.L. Barr, C. Xu, J. Kroft, Y. Feng, K. Wigg, G. Zai, R. Tannock, R. Schachar, M. Malone, W. Roberts, M.M. Nothen, F. Grunhage, D.J. Vandenbergh, G. Uhl, G. Sunohara, N. King, and J.L. Kennedy Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder Biological Psychiatry 49 2001 333 339
5. R. Bosse, F. Fumagalli, M. Jaber, B. Giros, R.R. Gainetdinov, W.C. Wetsel, C. Missale, and M.G. Caron Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter Neuron 19 1997 127 138
6. W.E. Bunney Jr., and B.L. Garland A second generation catecholamine hypothesis Pharmacopsychiatria 15 1982 111 115
7. M. Cargill, D. Altshuler, J. Ireland, P. Sklar, K. Ardlie, N. Patil, C.R. Lane, E.P. Lim, N. Kalayanaraman, J. Nemesh, L. Ziaugra, L. Friedland, A. Rolfe, J. Warrington, R. Lipshutz, G.O. Daley, and E.S. Lander Characterization of single-nucleotide polymorphisms in coding regions of human genes Nature Genetics 22 1999 231 238
8. A. Carlsson Perspectives on the discovery of central monoaminergic neurotransmission Annual Review of Neuroscience 10 1987 19 40
9. K.D. Chang, H. Steiner, and T.A. Ketter Psychiatric phenomenology of child and adolescent bipolar offspring Journal of the American Academy of Child and Adolescent Psychiatry 39 2000 453 460
10. C.K. Chen, S.L. Chen, J. Mill, Y.S. Huang, S.K. Lin, S. Curran, S. Purcell, P. Sham, and P. Asherson The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample Molecular Psychiatry 8 2003 393 396
11. 123I]IPT SPET in children with attention deficit hyperactivity disorder European Journal of Nuclear Medicine and Molecular Imaging 30 2003 306 311
12. J.C. Cohen, R.S. Kiss, A. Pertsemlidis, Y.L. Marcel, R. McPherson, and H.H. Hobbs Multiple rare alleles contribute to low plasma levels of HDL cholesterol Science 305 2004 869 872
13. C.K. Conners, D. Erhardt, and E. Sparrow Conner's Adult ADHD Rating Scales (CAARS) 1998 NCS Pearson, Inc. Minneapolis, MN
14. E.H. Cook Jr., M.A. Stein, M.D. Krasowski, N.J. Cox, D.M. Olkon, J.E. Kieffer, and B.L. Leventhal Association of attention-deficit disorder and the dopamine transporter gene American Journal of Human Genetics 56 1995 993 998
15. J.R. Cooper, F.E. Bloom, and R.H. Roth The Biochemical Basis of Neuropharmacology 1996 Oxford University Press New York
16. S. Curran, J. Mill, E. Tahir, L. Kent, S. Richards, A. Gould, L. Huckett, J. Sharp, C. Batten, S. Fernando, F. Ozbay, Y. Yazgan, E. Simonoff, M. Thompson, E. Taylor, and P. Asherson Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples Molecular Psychiatry 6 2001 425 428
17. G. Daly, Z. Hawi, M. Fitzgerald, and M. Gill Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Molecular Psychiatry 4 1999 192 196
18. D.J. Diehl, and S. Gershon The role of dopamine in mood disorders Comprehensive Psychiatry 33 1992 115 120
19. K.A. Dienes, K.D. Chang, C.M. Blasey, N.E. Adleman, and H. Steiner Characterization of children of bipolar parents by parent report CBCL Journal of Psychiatric Research 36 2002 337 345
20. S. DiMaio, N. Grizenko, and R. Joober Dopamine genes and attention-deficit hyperactivity disorder: a review Journal of Psychiatry and Neuroscience 28 2003 27 38
21. L.A. Doucette-Stamm, D.J. Blakely, J. Tian, S. Mockus, and J.I. Mao Population genetic study of the human dopamine transporter gene (DAT1) Genetic Epidemiology 12 1995 303 308
22. D.D. Dougherty, A.A. Bonab, T.J. Spencer, S.L. Rauch, B.K. Madras, and A.J. Fischman Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 1999 2132 2133
23. 99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment European Journal of Nuclear Medicine 27 2000 1518 1524
24. S.V. Faraone, J. Biederman, J. Wozniak, E. Mundy, D. Mennin, and D. O'Donnell Is comorbidity with ADHD a marker for juvenile-onset mania? Journal of the American Academy of Child and Adolescent Psychiatry 36 1997 1046 1055
25. S. Fuke, S. Suo, N. Takahashi, H. Koike, N. Sasagawa, and S. Ishiura The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression Pharmacogenomics Journal 1 2001 152 156
26. R.R. Gainetdinov, and M.G. Caron Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD Journal of the American Academy of Child and Adolescent Psychiatry 40 2001 380 382
27. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, and M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
28. E. Galili-Weisstub, S. Levy, A. Frisch, V. Gross-Tsur, E. Michaelovsky, A. Kosov, A. Meltzer, T. Goltser, A. Serretti, C. Cusin, A. Darvasi, E. Inbar, A. Weizman, and R.H. Segman Dopamine transporter haplotype and attention-deficit hyperactivity disorder Molecular Psychiatry 10 2005 617 618
29. J. Gelernter, H.R. Kranzler, S.L. Satel, and P.A. Rao Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 11 1994 195 200
30. J. Gelernter, H. Kranzler, and J. Lacobelle Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)) Genomics 52 1998 289 297
31. B. Geller, B. Zimerman, M. Williams, M.P. Delbello, K. Bolhofner, J.L. Craney, J. Frazier, L. Beringer, and M.J. Nickelsburg DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls J Child Adolesc Psychopharmacol 12 2002 11 25
32. R.H. Gerner, R.M. Post, and W.E. Bunney Jr. A dopaminergic mechanism in mania American Journal of Psychiatry 133 1976 1177 1180
33. M. Gill, G. Daly, S. Heron, Z. Hawi, and M. Fitzgerald Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Molecular Psychiatry 2 1997 311 313
34. B. Giros, S. El Mestikawy, N. Godinot, K. Zheng, H. Han, T. Yang-Feng, and M.G. Caron Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Molecular Pharmacology 42 1992 383 390
35. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
36. D.L. Grady, H.C. Chi, Y.C. Ding, M. Smith, E. Wang, S. Schuck, P. Flodman, M.A. Spence, J.M. Swanson, and R.K. Moyzis High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder Molecular Psychiatry 8 2003 536 545
37. T.A. Greenwood, M. Alexander, P.E. Keck, S. McElroy, A.D. Sadovnick, R.A. Remick, S.H. Shaw, and J.R. Kelsoe Segmental linkage disequilibrium within the dopamine transporter gene Molecular Psychiatry 7 2002 165 173
38. F. Grunhage, T.G. Schulze, D.J. Muller, M. Lanczik, E. Franzek, M. Albus, M. Borrmann-Hassenbach, M. Knapp, S. Cichon, W. Maier, M. Rietschel, P. Propping, and M.M. Nothen Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) Molecular Psychiatry 5 2000 275 282
39. J. Hardy, M.R. Cookson, and A. Singleton Genes and parkinsonism Lancet Neurol 2 2003 221 228
40. Z. Hawi, N. Lowe, A. Kirley, F. Gruenhage, M. Nothen, T. Greenwood, J. Kelsoe, M. Fitzgerald, and M. Gill Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci Molecular Psychiatry 8 2003 299 308
41. J. Holmes, A. Payton, J.H. Barrett, T. Hever, H. Fitzpatrick, A.L. Trumper, R. Harrington, P. McGuffin, M. Owen, W. Ollier, J. Worthington, and A. Thapar A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder Molecular Psychiatry 5 2000 523 530
42. S.R. Jones, R.R. Gainetdinov, X.T. Hu, D.C. Cooper, R.M. Wightman, F.J. White, and M.G. Caron Loss of autoreceptor functions in mice lacking the dopamine transporter Nature Neuroscience 2 1999 649 655
43. J. Kaufman, B. Birmaher, D. Brent, U. Rao, C. Flynn, P. Moreci, D. Williamson, and N. Ryan Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data Journal of the American Academy of Child and Adolescent Psychiatry 36 1997 980-988
44. K.H. Krause, S.H. Dresel, J. Krause, H.F. Kung, and K. Tatsch Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neuroscience Letters 285 2000 107 110
45. K.R. Krishnan Psychiatric and medical comorbidities of bipolar disorder Psychosomatic Medicine 67 2005 1 8
46. C. Lerman, N.E. Caporaso, J. Audrain, D. Main, E.D. Bowman, B. Lockshin, N.R. Boyd, and P.G. Shields Evidence suggesting the role of specific genetic factors in cigarette smoking Health Psychology 18 1999 14 20
47. Q. Li, Z. Liu, H. Monroe, and C.T. Culiat Integrated platform for detection of DNA sequence variants using capillary array electrophoresis Electrophoresis 23 2002 1499 1511
48. Mazei-Robison, M.S., Blakely, R.D., 2005. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala. Neuropharmacology 49 (6) 737-749.
49. J. Mill, P. Asherson, C. Browes, U. D'Souza, and I. Craig Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR American Journal of Medical Genetics 114 2002 975 979
50. G.M. Miller, and B.K. Madras Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression Molecular Psychiatry 7 2002 44 55
51. - neurotransmitter transporters Journal of Neurochemistry 71 1998 1785 1803
52. N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, J. Lappalainen, G. Rudnick, and D.L. Murphy Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype Molecular Psychiatry 8 895 2003 933 936
53. C.G. Palmer, J.N. Bailey, C. Ramsey, D. Cantwell, J.S. Sinsheimer, M. Del'Homme, J. McGough, J.A. Woodward, R. Asarnow, J. Asarnow, S. Nelson, and S.L. Smalley No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample Psychiatric Genetics 9 1999 157 160
54. A.M. Persico, G. Bird, F.H. Gabbay, and G.R. Uhl D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers Biological Psychiatry 40 1996 776 784
55. R.J. Ralph, M.P. Paulus, F. Fumagalli, M.G. Caron, and M.A. Geyer Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists Journal of Neuroscience 21 2001 305 313
56. R.J. Ralph-Williams, M.P. Paulus, X. Zhuang, R. Hen, and M.A. Geyer Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system Biological Psychiatry 53 2003 352 359
57. R.M. Rodriguiz, R. Chu, M.G. Caron, and W.C. Wetsel Aberrant responses in social interaction of dopamine transporter knockout mice Behavioural Brain Research 148 2004 185 198
58. C. Spielewoy, C. Roubert, M. Hamon, M. Nosten-Bertrand, C. Betancur, and B. Giros Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice Behavioural Pharmacology 11 2000 279 290
59. P.H. St George-Hyslop Molecular genetics of Alzheimer's disease Biological Psychiatry 47 2000 183 199
60. D.J. States, and W. Gish Combined use of sequence similarity and codon bias for coding region identification Journal of Computational Biology 1 1994 39 50
61. Stein, M.A., Sarampote, C.S., Waldman, I.D., Robb, A.S., Conlon, C., Pearl, P.L., Black, D.O., Seymour, K.E., Newcorn, J.H., 2003. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 112, e404.
62. M.A. Stein, I.D. Waldman, C.S. Sarampote, K.E. Seymour, A.S. Robb, C. Conlon, S.J. Kim, and E.H. Cook Dopamine transporter genotype and methylphenidate dose response in children with ADHD Neuropsychopharmacology 30 2005 1374 1382
63. M. Tatsumi, K. Groshan, R.D. Blakely, and E. Richelson Pharmacological profile of antidepressants and related compounds at human monoamine transporters European Journal of Pharmacology 340 1997 249 258
64. A. Thapar, J. Holmes, K. Poulton, and R. Harrington Genetic basis of attention deficit and hyperactivity British Journal of Psychiatry 174 1999 105 111
65. R.D. Todd, Y.J. Jong, E.A. Lobos, W. Reich, A.C. Heath, and R.J. Neuman No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins American Journal of Medical Genetics 105 2001 745 748
66. C.H. van Dyck, D.M. Quinlan, L.M. Cretella, J.K. Staley, R.T. Malison, R.M. Baldwin, J.P. Seibyl, and R.B. Innis Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder American Journal of Psychiatry 159 2002 309 312
67. D.J. Vandenbergh, A.M. Persico, A.L. Hawkins, C.A. Griffin, X. Li, E.W. Jabs, and G.R. Uhl Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 14 1992 1104 1106
68. D.J. Vandenbergh, M.D. Thompson, E.H. Cook, E. Bendahhou, T. Nguyen, M.D. Krasowski, D. Zarrabian, D. Comings, E.M. Sellers, R.F. Tyndale, S.R. George, B.F. O'Dowd, and G.R. Uhl Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations Molecular Psychiatry 5 2000 283 292
69. N.D. Volkow, G. Wang, J.S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y. Ding, S.J. Gatley, A. Gifford, and D. Franceschi Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain Journal of Neuroscience 21 2001 RC121
70. I.D. Waldman, D.C. Rowe, A. Abramowitz, S.T. Kozel, J.H. Mohr, S.L. Sherman, H.H. Cleveland, M.L. Sanders, J.M. Gard, and C. Stever Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity American Journal of Human Genetics 63 1998 1767 1776
71. S.A. West, S.M. Strakowski, K.W. Sax, K.L. Minnery, S.L. McElroy, and P.E. Keck Jr. The comorbidity of attention-deficit hyperactivity disorder in adolescent mania: potential diagnostic and treatment implications Psychopharmacology Bulletin 31 1995 347 351
72. B.G. Winsberg, and D.E. Comings Association of the dopamine transporter gene (DAT1) with poor methylphenidate response Journal of the American Academy of Child and Adolescent Psychiatry 38 1999 1474 1477
73. G. Winterer, and D.R. Weinberger Genes, dopamine and cortical signal-to-noise ratio in schizophrenia Trends in Neurosciences 27 2004 683 690
74. Wozniak, J., Biederman, J., Kiely, K., Ablon, J.S., Faraone, S.V., Mundy, E., Mennin, D., 1995a. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry 34, 867-876.
75. Wozniak, J., Biederman, J., Mundy, E., Mennin, D., Faraone, S.V., 1995b. A pilot family study of childhood-onset mania. Journal of the American Academy of Child and Adolescent Psychiatry 34, 1577-1583.